MasterPharm Recalls Finasteride Plus Capsules Due to Minoxidil Contamination
MasterPharm LLC is recalling Finasteride Plus 1.25 mg capsules because they were found to contain minoxidil. The recall covers 7,260 capsules distributed nationwide.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class I recall, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death. The rubric mandates a score of at least 4 for FDA Class I recalls.
Plain-English summary
MasterPharm LLC is recalling Finasteride Plus 1.25 mg capsules, available in 30-count and 90-count bottles. The product is a compounded medication not intended for resale. The recall involves 7,260 capsules distributed nationwide in the United States.
The recall was initiated due to cross-contamination with other products. Testing revealed that the Finasteride Plus capsules contained minoxidil, an ingredient not listed on the product label. The affected lot is identified as Lot #02-27-2020:04@11 with an expiration date of August 25, 2020.
Consumers who possess these capsules should stop using them and contact their healthcare provider or pharmacist for guidance. The product was manufactured by MasterPharm LLC, located at 115-02 Liberty Ave, Richmond Hill, NY 11419.
The recalled product
- Product
- Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Compounded Medication
- Affected units
- 7,260
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #02-27-2020:04@11
- Exp. August 25
- 2020.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Testosterone/Anastrozole Pellets Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
Same hazard · cross contamination
See all →- HighFDA Recalls Performance Pro Nitrile Gloves Due to Defects
FDA (Devices) · 2026-10-07
- HighFDA Recalls Defective Blue Nitrile Patient Examination Gloves
FDA (Devices) · 2026-10-07
- HighFDA Recalls Opportunity Pro Nitrile Gloves Due to Manufacturing Defects
FDA (Devices) · 2026-10-07
- ModerateSage Products Recalls Chlorhexidine Gluconate Cloth Due to Cross Contamination
FDA (Drugs) · 2026-09-09
- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
Similar recalls
- ModerateMasterPharm Recalls Finasteride Plus Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Minoxidil/Biotin Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- SevereMasterPharm Recalls Compounded Minoxidil, Biotin, and Spironolactone Capsules
FDA (Drugs) · 2020-07-08
- ModerateMasterPharm Recalls Minoxidil/Biotin/Spironolactone Capsules Due to Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Tadalafil 7 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Tadalafil 26 mg Capsules Due to Processing Controls
FDA (Drugs) · 2020-08-05